Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

A model for overcoming challenges in academic pediatric medical device innovation.

Fischer GA, Wells SM, Rebuffoni JF, Peterson BM, LeBien TW.

J Clin Transl Sci. 2019 Feb;3(1):5-11. doi: 10.1017/cts.2019.370.

2.

Novel team-based approaches to advance academic translational research.

Wells SM, Rebuffoni JF, LeBien TW.

Clin Transl Sci. 2014 Dec;7(6):427-9. doi: 10.1111/cts.12211. Epub 2014 Sep 19. No abstract available.

3.

IL-7R expression and IL-7 signaling confer a distinct phenotype on developing human B-lineage cells.

Nodland SE, Berkowska MA, Bajer AA, Shah N, de Ridder D, van Dongen JJ, LeBien TW, van Zelm MC.

Blood. 2011 Aug 25;118(8):2116-27. doi: 10.1182/blood-2010-08-302513. Epub 2011 Jun 16.

4.

Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria.

Hermanson D, Addo SN, Bajer AA, Marchant JS, Das SG, Srinivasan B, Al-Mousa F, Michelangeli F, Thomas DD, Lebien TW, Xing C.

Mol Pharmacol. 2009 Sep;76(3):667-78. doi: 10.1124/mol.109.055830. Epub 2009 Jun 26.

5.

Stable gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system.

Xue X, Huang X, Nodland SE, Mátés L, Ma L, Izsvák Z, Ivics Z, LeBien TW, McIvor RS, Wagner JE, Zhou X.

Blood. 2009 Aug 13;114(7):1319-30. doi: 10.1182/blood-2009-03-210005. Epub 2009 May 4.

PMID:
19414858
6.

B lymphocytes: how they develop and function.

LeBien TW, Tedder TF.

Blood. 2008 Sep 1;112(5):1570-80. doi: 10.1182/blood-2008-02-078071. Review.

7.
8.

Murine and human IL-7 activate STAT5 and induce proliferation of normal human pro-B cells.

Johnson SE, Shah N, Panoskaltsis-Mortari A, LeBien TW.

J Immunol. 2005 Dec 1;175(11):7325-31.

9.

Enhancement of stress-induced apoptosis in B-lineage cells by caspase-9 inhibitor.

Shah N, Asch RJ, Lysholm AS, Lebien TW.

Blood. 2004 Nov 1;104(9):2873-8. Epub 2004 Jul 8.

PMID:
15242874
10.

B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression.

Bertrand FE, Spengeman JD, Shah N, LeBien TW.

Leukemia. 2003 Dec;17(12):2454-9.

PMID:
14562113
11.

Arginine: an unusual dietary requirement of pre-B lymphocytes?

LeBien TW.

J Clin Invest. 2002 Nov;110(10):1411-3. Review. No abstract available.

12.

Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein.

Bertrand FE, Vogtenhuber C, Shah N, LeBien TW.

Blood. 2001 Dec 1;98(12):3398-405.

PMID:
11719380
13.
14.

Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors.

Fink JR, LeBien TW.

Exp Hematol. 2001 Apr;29(4):490-8.

PMID:
11301189
15.

Notch-1 and Notch-2 exhibit unique patterns of expression in human B-lineage cells.

Bertrand FE, Eckfeldt CE, Lysholm AS, LeBien TW.

Leukemia. 2000 Dec;14(12):2095-102.

16.

Microenvironmental influences on human B-cell development.

Bertrand FE, Eckfeldt CE, Fink JR, Lysholm AS, Pribyl JA, Shah N, LeBien TW.

Immunol Rev. 2000 Jun;175:175-86. Review. Erratum in: Immunol Rev 2000 Dec;178:186.

PMID:
10933602
17.

Fates of human B-cell precursors.

LeBien TW.

Blood. 2000 Jul 1;96(1):9-23. Review.

PMID:
10891425
18.

Biased VH gene usage in early lineage human B cells: evidence for preferential Ig gene rearrangement in the absence of selection.

Rao SP, Riggs JM, Friedman DF, Scully MS, LeBien TW, Silberstein LE.

J Immunol. 1999 Sep 1;163(5):2732-40.

19.

Comparative studies of different stromal cell microenvironments in support of human B-cell development.

Kurosaka D, LeBien TW, Pribyl JA.

Exp Hematol. 1999 Aug;27(8):1271-81.

PMID:
10428504
21.

B-cell lymphopoiesis in mouse and man.

LeBien TW.

Curr Opin Immunol. 1998 Apr;10(2):188-95. Review.

PMID:
9602308
22.

Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cells.

Weng WK, Shah N, O'Brien D, Van Ness B, LeBien TW.

J Immunol. 1997 Dec 1;159(11):5502-8.

PMID:
9548490
24.

Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6.

Billadeau D, Liu P, Jelinek D, Shah N, LeBien TW, Van Ness B.

Cancer Res. 1997 Jun 1;57(11):2268-75.

25.

Interleukin 7 independent development of human B cells.

Prieyl JA, LeBien TW.

Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10348-53.

26.

A little bit of CD history.

LeBien TW.

Transfusion. 1996 Mar;36(3):197-9. No abstract available.

PMID:
8604500
28.

In vitro studies of human B lymphopoiesis.

Pribyl JR, Dittel BN, LeBien TW.

Ann N Y Acad Sci. 1995 Sep 29;764:9-18. Review. No abstract available.

PMID:
7486595
29.
30.

Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6.

Billadeau D, Jelinek DF, Shah N, LeBien TW, Van Ness B.

Cancer Res. 1995 Aug 15;55(16):3640-6.

31.

Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli.

Fang W, Rivard JJ, Ganser JA, LeBien TW, Nath KA, Mueller DL, Behrens TW.

J Immunol. 1995 Jul 1;155(1):66-75.

PMID:
7602123
32.
35.

Transforming growth factor-beta regulates normal human pre-B cell differentiation.

Rehmann JA, LeBien TW.

Int Immunol. 1994 Feb;6(2):315-22.

PMID:
8155604
37.

Functional effect of IL-7-enhanced CD19 expression on human B cell precursors.

Wolf ML, Weng WK, Stieglbauer KT, Shah N, LeBien TW.

J Immunol. 1993 Jul 1;151(1):138-48.

PMID:
7686930
39.

Development of a bone marrow culture for maintenance and growth of normal human B cell precursors.

Wolf ML, Buckley JA, Goldfarb A, Law CL, LeBien TW.

J Immunol. 1991 Nov 15;147(10):3324-30.

PMID:
1719075
40.

Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging.

Weisdorf DJ, Haake R, Miller WJ, McGlave PB, LeBien TW, Vallera DA, Lasky LC, Kim TH, Peterson BA, Ramsay NK, et al.

Bone Marrow Transplant. 1991 Aug;8(2):135-42.

PMID:
1933055
41.

Expression of interleukin-4 receptors on early human B-lineage cells.

Law CL, Armitage RJ, Villablanca JG, LeBien TW.

Blood. 1991 Aug 1;78(3):703-10.

PMID:
1859884
42.

Biochemical and histochemical characterization of a murine tubular antigen.

Davis ID, LeBien TW, Lindman BJ, Platt JL.

J Am Soc Nephrol. 1991 Apr;1(10):1153-61.

43.
44.

Analysis of expression and function of CD40 on normal and leukemic human B cell precursors.

Law CL, Wörmann B, LeBien TW.

Leukemia. 1990 Nov;4(11):732-8.

PMID:
1700237
45.

Analysis of immunoglobulin and T-cell receptor gene rearrangements in human fetal bone marrow B lineage cells.

LeBien TW, Elstrom RL, Moseley M, Kersey JH, Griesinger F.

Blood. 1990 Sep 15;76(6):1196-200.

PMID:
2144776
47.

Ontogeny of normal human B-cell and T-cell precursors and its relation to leukemogenesis.

LeBien TW, Villablanca JG.

Hematol Oncol Clin North Am. 1990 Aug;4(4):835-47. Review.

PMID:
2228898
48.

Differentiation of normal human pre-B cells in vitro.

Villablanca JG, Anderson JM, Moseley M, Law CL, Elstrom RL, LeBien TW.

J Exp Med. 1990 Jul 1;172(1):325-34.

49.

Multiparameter flow cytometric analysis of human fetal bone marrow B cells.

LeBien TW, Wörmann B, Villablanca JG, Law CL, Steinberg LM, Shah VO, Loken MR.

Leukemia. 1990 May;4(5):354-8.

PMID:
1697009
50.

Allogeneic and autologous bone marrow transplantation for acute lymphoblastic leukemia.

Weisdorf D, Ramsay N, LeBien T, Woods W, Bostrom B, Nesbit M, Vallera D, Uckun F, Goldman A, Kim T, et al.

Haematol Blood Transfus. 1990;33:679-83. No abstract available.

PMID:
2323666

Supplemental Content

Loading ...
Support Center